This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal

WITH SPECIAL REFERENCE TO THE PRONTOSILS, SULFANILAMIDE AND SULFAPYRIDINE

JOHN A. KOLMER, M.D.

Arch Intern Med. 1940;65(4):671-743.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Until the discovery of the effectiveness of the original prontosil (the hydrochloride of 4-sulfonamido-2',4'-diaminoazobenzene) in the treatment of streptococcic and staphylococcic infections the chemotherapy of systemic bacterial diseases was largely disappointing. It is true that certain dyes, like gentian violet and acriflavine base as well as various mercurial compounds, commanded considerable attention and extensive clinical trial, with encouraging results in individual cases; but in general, original hopes and expectations were not realized. Indeed, aside from the helpful effects of neoarsphenamine in the treatment of anthrax and the clinically inapplicable treatment of pneumococcic infections with ethylhydrocupreine (optochin) base and its soluble derivative ethylhydrocupreine hydrochloride, the only site in which bacteria have been found vulnerable by systemic chemical attack has been the urinary tract, where conditions are exceptional. But, as I wrote in 1936:

I by no means share the skepticism so frequently expressed in regard to the future of the chemotherapy . . . [Full Text PDF of this Article]

Author Affiliations
Professor of Medicine, Temple University School of Medicine, and Director of the Research Institute of Cutaneous Medicine. PHILADELPHIA